Targeting histone deacetylase in cardiac diseases

Targeting histone deacetylase in cardiac diseases

Histone deacetylases (HDAC) catalyze the removal of acetylation modifications on histones and non-histone proteins, which regulates gene expression and other cellular processes. HDAC inhibitors (HDACi), approved anti-cancer agents, emerge as a potential new therapy for heart diseases. Cardioprotecti...

Cijeli opis

Bibliografski detalji
Glavni autori: Jiao Lu, Sichong Qian, Zheng Sun
Format: Članak
Jezik:English
Izdano: Frontiers Media S.A. 2024-06-01
Serija:Frontiers in Physiology
Teme:
histone deacetylase
histone deacetylase inhibitor
cardiac hypertrophy
myocardial infarction
ischemic reperfusion
heart failure
Online pristup:https://www.frontiersin.org/articles/10.3389/fphys.2024.1405569/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2024.1405569/full

Slični predmeti